Market Analysis
10 minutes ago

Shutdown Enters 5th Day, Halting Key Economic Data Releases

The ongoing US government shutdown is delaying critical jobs and inflation reports, creating an information vacuum for investors and the Federal Reserve.

Read More
Sector Analysis
41 minutes ago

US Semiconductor Sector Eyes Windfall From Proposed Tax Overhaul

Proposed 'OBBBA' legislation would hike tax credits for new domestic chip plants to 35%, aiming to accelerate 'Made in America' initiatives.

Read More
FDA & Biotech
2 hours ago

FDA Greenlights New Lung Cancer Drug From Jazz and Roche

Combination therapy approval for small cell lung cancer offers a new standard of care and a bullish signal for the pharmaceutical sector.

Read More
Sector Analysis
4 hours ago

California Rocks Gig Economy with Driver Unionization Law

Landmark bill grants Uber and Lyft drivers collective bargaining rights, signaling a potential shift in the gig work model.

Read More
FDA & Biotech
5 hours ago

Roche's Tecentriq Combo Wins Key FDA Nod for Lung Cancer

First-of-its-kind maintenance therapy approved for extensive-stage small cell lung cancer, a historically difficult-to-treat malignancy.

Read More
FDA & Biotech
8 hours ago

Alto Neuroscience Stock Jumps on FDA Fast Track for Schizophrenia Drug

The designation for ALTO-101 targets cognitive impairment, a debilitating aspect of schizophrenia with no currently approved treatments.

Read More
Market Analysis
8 hours ago

Bitcoin Surges to Record $125K High Amid Supply Squeeze

Investor demand drives prices to new all-time highs as Bitcoin balances on exchanges plummet to a six-year low.

Read More
Market Analysis
11 hours ago

US Markets Navigate Uncertainty Amid Shutdown and Fed Rate Cut

Fiscal paralysis in Washington delays key economic data while the central bank cuts rates to support a cooling economy, creating a complex outlook for investors.

Read More